-
Manufacturing, Supply Chain & Infrastructure3 weeks agoElectrical Signals Sharpen Bioprocess Control
Electrical signatures could give bioprocess engineers an earlier view of cell health, detecting apoptosis, refining harvest timing, and moving monitoring from destructive offline assays toward rapid,...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoBig Data Opportunities in Biomanufacturing
Industry-wide standardization and collaboration leverage big data in ways that help companies unleash optimizations enterprise-wide while simultaneously advancing industry knowledge, but succeeding also takes a lot...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoKagan, Soai Win 2026 Nobel Prize in Chemistry for Discoveries Related to Asymmetric Organic Synthesis
Henri Kagan, PhD, and Kenso Soai, PhD, shared this year's award for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis respectively. The post...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoBayer commits $2.2B to build pharma manufacturing plant in Ohio
The investment will equip Bayer to make oncology, cardiovascular and renal care ingredients and drugs.
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoBiologics Standards for Innovation, Quality and Access
This GEN Spotlight on Biologics Standards for Innovation, Quality and Access brings together experts from across biopharma, standards development, and analytical science to examine the challenges...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoInside All-ScaleFlow: Continuous End-to-End RNA-LNP Manufacturing
Dillico’s GMP-ready Continuous Manufacturing by Engineering, Not Hype The post Inside All-ScaleFlow: Continuous End-to-End RNA-LNP Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoCompliance concerns hinder rollout of AI in drug manufacturing: Survey
While AI is taking off in biopharma for administrative tasks and drug discovery efforts, more than 90% of drugmakers have yet to commit to scaling AI...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoAstraZeneca opens new R&D centre in Cambridge, US
The 18-storey, 570,000ft² facility at 290 Binney Street features ten floors of interconnecting laboratories equipped with continuous automation, robotics, and agentic AI. Combined with the company’s...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoBehind (cell) walls
Nature Biotechnology, Published online: 05 October 2026; doi:10.1038/s41587-026-03356-1While mammalian delivery technologies are advancing to translation at an exceptional rate, delivery to plant tissues faces challenges, limiting...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoNovo faces delay in US review of haemophilia drug
The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
STAT+: HHS moves to allow compounding of some unapproved peptides
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
